Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells
US7098195B2 · kind B2 · utility
1Cited by
1References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 26, 2002 |
| Grant date | Aug 29, 2006 |
| Priority date | — |
| Expiry date | Nov 26, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated N-acetylglucosamines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.